Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States.
Iterum Therapeutics stock last closed at $1.03, down 4.63% from the previous day, and has decreased 34.81% in one year. It has overperformed other stocks in the Biotechnology industry by 0.43 percentage points. Iterum Therapeutics stock is currently +27.48% from its 52-week low of $0.81, and -65.89% from its 52-week high of $3.02.
There are currently 34.58M ITRM shares outstanding. The market value of ITRM is $35.62M. In the last 24 hours, 782,158 ITRM shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy ITRM stock.
In our opinion, eToro is the best stock brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, it's time to fill out some personal information so you can buy ITRM today.
Now that you've finished signing up on the best stock trading app for beginners, you need to deposit funds:
Check out the walkthrough below if you need help transferring money into your investment account.
Once you have chosen the best place to buy Iterum Therapeutics stock, it's critical to research their stock before you buy, so you actually understand the risk as well as the opportunity.
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on ITRM's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge ITRM's intrinsic value.
You can access additional valuation analysis on ITRM's stock here.
You can dive deeper into what analysts are projecting on the Iterum Therapeutics stock forecast page.
Last year, ITRM revenue was $0.00. Over the last five year, ITRM's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 44.31%.
Dive into ITRM's earnings and revenue performance here.
In the past year, executives and large shareholders at ITRM have not bought or sold any shares.
Get more info about who owns ITRM shares here.
No, Iterum Therapeutics doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main options:
Click the Open Trade button and your broker will place your order.
If you need more help buying stocks on eToro, click the helpful video below:
Now that you own some ITRM stock, you'll want to keep up with your new stock purchase.
Add ITRM to a watchlist to track the latest developments regarding your ITRM stock.
To reiterate, here are the 6 steps to buy Iterum Therapeutics stock:
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your new investment in Iterum Therapeutics, click the button below.